Comparison of Voriconazole Concentration in the Aqueous Humor and Vitreous between Non-Scraped and Scraped Corneal Epithelium Groups after Topical 1% Voriconazole Application

REFERENCES

• Wykoff CC, Flynn HW, Miller D, et al. Exogenous fungal endophthalmitis: Microbiology and clinical outcomes. Ophthalmology. 2008;115:1501–1507.
   PubMed Web of Science ®Google Scholar
• Pflugfelder SC, Flynn HW, Zwickey TA. Exogenous fungal endophthalmitis. Ophthalmology. 1988;95:19–30.
   PubMed Web of Science ®Google Scholar
• Dursun D, Fernandez V, Miller D, et al. Advanced Fusarium keratitis progressing to endophthalmitis. Cornea. 2003;22:300–303.
   PubMed Web of Science ®Google Scholar
• Rosenberg KD, Flynn HW, Alfonso EC, et al. Fusarium endophthalmitis following keratitis associated with contact lenses. Ophthalmic Surg Lasers Imaging. 2006;37:310–313.
   PubMedGoogle Scholar
• Upadhyay MP, Karmacharya PC, Koirala S. Epidemiologic characteristics, predisposing factors, and etiologic diagnosis of corneal ulceration in Nepal. Am J Ophthalmol. 1991;111:92–99.
   PubMed Web of Science ®Google Scholar
• Sharma S, Srinivasan M, George C. The current status of Fusarium species in mycotic keratitis in south India. Indian J Med Microbiol. 1993;11:140–147.
   Google Scholar
• Rosa RH, Miller D, Alfonso EC. The changing spectrum of fungal keratitis in South Florida. Ophthalmology. 1994;101:1005–1013.
   PubMed Web of Science ®Google Scholar
• Gallis HA, Drew RH, Pickard WW. Amphoterecin B: 30 years of clinical experience. Rev Infect Dis. 1990;12:308–329.
   PubMedGoogle Scholar
• Sabo JA, Abdel-Rahman SM. Voriconazole: A new triazole antifungal. Ann Pharmacother. 2000;34:1032–1043.
   PubMed Web of Science ®Google Scholar
• Hariprasad SM, Mieler WF, Holz ER, et al. Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans. Arch Ophthalmol. 2004;122:42–47.
   PubMed Web of Science ®Google Scholar
• Perfect JR, Marr KA, Walsh TJ. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin Infect Dis. 2003;36:1122–1131.
   PubMed Web of Science ®Google Scholar
• Abel R, Boyle GL. Dissecting ocular tissue for intraocular drug studies. Invest Ophthalmol. 1976;15:216–219.
   PubMedGoogle Scholar
• Prajna NV, John RK, Nirmalan PK. A randomised clinical trial comparing 2% econazole and 5% natamycin for the treatment of fungal keratitis. Br J Ophthlamol. 2003;87:1235–1237.
   PubMed Web of Science ®Google Scholar
• Yilmaz S, True M, Maden A. Efficacy of intracameral amphotericin B injection in the management of refractory keratomycosis and endophthalmitis. Cornea. 2007;26:398–402.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Messer SA, Hollis RJ. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: Report from SENTRY Antimicrobial Surveillance Program, 2000. Antimicrob Agents Chemother. 2002;46:1032–1037.
   PubMed Web of Science ®Google Scholar
• Marangon FB, Miller D, Giaconi JA. In vitro investigation of voriconazole susceptibility for keratits and endopphthapmitis fungal pathogens. Am J Ophthalmol. 2004;137:820–825.
   PubMed Web of Science ®Google Scholar
• Shen YC, Wang MY, Wang CY, et al. Clearance of intravitreal voriconazole. Invest Ophthalmol Vis Sci. 2007;48: 2238–2241.
   PubMed Web of Science ®Google Scholar
• Vorwerk CK, Streit F, Binder L, et al. Aqueous humor concentration of voriconazole after topical administration in rabbits. Graefes Arch Clin Exp Ophthalmol. 2008;246:1179–1183.
   PubMedGoogle Scholar
• Zhou L, Glickman RD, Chen N, et al. Determination of voriconazole in aqueous humor by liquid chromatography-electrospray ionization-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2002;776:213–220.
   PubMed Web of Science ®Google Scholar
• Shen YC, Wang MY, Wang CY, et al. Pharmacokinetics of intracameral voriconazole injection. Antimicrob Agents Chemother. 2009;53:2156–2157.
   PubMedGoogle Scholar
• Sun MX, Chen JQ, Yao MC, et al. Ocular penetration and pharmacokinetics of topical voriconazole in rabbit eyes. Zhonghua Yan Ke Za Zhi. 2008;44:349–353.
   PubMedGoogle Scholar
• Vemulakonda GA, Hariprasad SM, Mieler WF, et al. Aqueous and vitreous concentrations following topical administration of 1% voriconazole in humans. Arch Ophthalmol. 2008;126:18–22.
   PubMed Web of Science ®Google Scholar
• Behrens-Baumann W. Mycosis of the Eye and its Adnexa. Basle: Karger, 1999; pp. 171–174.
   Google Scholar
• Liou SW, Chiu CJ, Wang IJ. Effect of intracameral injection of lidocaine and carbachol on the rabbit corneal endothelium. J Cataract Refract Surg. 2004;30:1351–1355.
   PubMed Web of Science ®Google Scholar
• Sponsel W, Chen N, Dang D, et al. Topical voriconazole as a novel treatment for fungal keratitis. Antimicrob Agents Chemother. 2006;50:262–268.
   PubMed Web of Science ®Google Scholar
• Arikan S, Lozano-Chiu M, Paetznick V, et al. Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species. J Clin Microbiol. 1999;37:3946–3951.
   PubMed Web of Science ®Google Scholar
• Marco F, Pfaller MA, Messer SA, et al. Antifungal activity of a new triazole, voriconazole (UK-109, 496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi. Med Mycol. 1998;36:433–436.
   PubMed Web of Science ®Google Scholar
• Denning DW, Hanson LH, Perlman AM, et al. In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents. Diagn Microbiol Infect Dis. 1992;15:21–34.
   PubMed Web of Science ®Google Scholar
• Klepser ME, Malone D, Lewis RE, et al. Evaluation of voriconazole pharmacodynamics using time-kill methodology. Antimicrob Agents Chemother. 2000;44:1917–1920.
   PubMed Web of Science ®Google Scholar
• Peters AM. Fundamentals of tracer kinetics for radiologists. Br J Radiol. 1998;71:1116–1129.
   PubMedGoogle Scholar
• Klyce SD, Crosson CE. Transport processes across the rabbit corneal epithelium: A review. Curr Eye Res. 1985;4:323–331.
   PubMed Web of Science ®Google Scholar
• Sasaki H, Yamamura K, Tei C, et al. Ocular permeability of FITC-dextran with absorption promoter for ocular delivery of peptide drug. J Drug Target. 1995;3:129–135.
   PubMed Web of Science ®Google Scholar
• Silling G. Fluconazole: Optimized antifungal therapy based on pharmacokinetics. Mycoses. 2002;45(Suppl 3):39–41.
   PubMedGoogle Scholar
• Chang SW, Chou SF, Chuang JL. Mechanical corneal epithelium scraping and ethanol treatment up-regulate cytokine gene expression differently in rabbit cornea. J Refract Surg. 2008;24:150–159.
   PubMedGoogle Scholar